Once again, a large number of broker notes hit the wires last week. Some of these notes were positive and some were bearish.
Three sell ratings that caught my eye are summarised below. Here's why top brokers think investors ought to sell these shares next week:
A2 Milk Company Ltd (ASX: A2M)
According to a note out of Citi, its analysts have retained their sell rating and cut the price target on this infant formula company's shares to $7.15. The broker made the move following the release of a2 Milk Company's disappointing half year results. Citi has reduced its estimates materially over the coming years to reflect the demand issues it is facing in the daigou channel and margin pressures across the business. The a2 Milk Company share price ended the week at $8.99.
Appen Ltd (ASX: APX)
A note out of Macquarie reveals that its analysts have retained their underperform rating and cut the price target on this artificial intelligence data services company's shares to $16.00. According to the note, the broker wasn't surprised that Appen fell short of expectations in FY 2020. Looking ahead, Macquarie has concerns that increased competition could weigh on pricing and lead to Appen falling short of expectations again. The Appen share price was fetching $16.69 at the end of last week.
InvoCare Limited (ASX: IVC)
Analysts at Macquarie also have retained their underperform rating and $9.30 price target on this funerals company's shares. This follows the release of a mixed full year result last week. According to the note, InvoCare fell short of expectations in FY 2020 due to one-offs. And while the broker is expecting a better performance this year, it does have concerns that rising costs could offset this. In light of this and its current valuation, it sees no reason to change its rating. The InvoCare share price ended the week at $11.23.
